
This Fund endeavors to produce daily investment performance equivalent to two times (200%) the daily percentage movement of Lemonade, Inc. (NYSE: LMND) shares, prior to the deduction of fees and expenses. Crucially, the Fund's investment goal is solely intended to be met on a daily basis and is not designed for holding periods longer than a single trading day.
Is LMNX's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

NEW YORK, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Tidal Financial Group and Defiance ETFs today announced their decision to close and liquidate eight exchange-traded funds listed on various exchanges as indicated below: Defiance Daily Target 2X Long LMND ETF (Nasdaq: LMNX)Defiance Daily Target 2X Long ZETA ETF (NYSE Arca: ZETX)Defiance Daily Target 2X Long DKNG ETF (Nasdaq: DKNX)Defiance Daily Target 2X Short OKLO ETF (NYSE Arca: OKLS)Defiance Daily Target 2X Long MP ETF (NYSE Arca: MPL)Defiance Daily Target 2X Short HOOD ETF (NYSE Arca: HOOZ)Defiance Daily Target 2X Long RKT ETF (Cboe: RKTL)Defiance 2X Daily Long Pure Drone and Aerial Automation ETF (Cboe: DRNL) The Board of Trustees of Tidal Trust II approved this action as part of Defiance's ongoing review of its product lineup and its commitment to offering investors a focused suite of strategies aligned with evolving market conditions and investor demand. The final day of trading for the funds on their respective exchanges will be Thursday, August 27, 2026.

Defiance Daily Target 2X Long LMND ETF (NASDAQ: LMNX - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Volatility and Risk

Institutional and Insider Ownership 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 87.8% of Defiance Daily Target 2X Long LMND ETF shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Comparatively, 6.6% of Defiance Daily Target 2X Long LMND

Valuation and Earnings This table compares Defiance Daily Target 2X Long LMND ETF and Minerva Surgical"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Defiance Daily Target 2X Long LMND ETF $437.66 million 0.01 $15.17 million $0.51 30.43 Minerva Surgical $51.69 million 0.00 -$34.11 million

Leveraged ETFs surged amid market turmoil as stocks slid and commodities swung wildly. Inverse plays dominated -- here are last week's top winners.